Atherotech Diagnostics Lab has announced a 30 percent expansion of its Lakeshore Crossings Business Park lab facility to better meet rising demand for advanced cholesterol screening and other clinical laboratory services.

The announcement comes after the company boosted its employment level by an estimated 30 percent this year with plans to add 40 employees through 2012.

“Atherotech is engaged in a fairly aggressive growth pattern, which is good for the business community and good for Birmingham, especially in a down economy,” said Dan Lovell, director of the Office Group at Graham & Co. .Graham & Co. Latest from The Business Journals Real estate roundup: BASS lands on 280EGS inks deals in Avondale, GraymontReal Estate Roundup: Hoar starts hospital construction Follow this company ., which is representing Atherotech in the expansion.

Atherotech CEO Michael Mullen attributed the expansion to increased sales and new diagnostic testing capabilities.

[ Read article at ]